HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Tiaprofenic Acid

HCID 5468
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
33005-95-7
Standard SMILES
CC(C(=O)O)c1ccc(C(=O)c2ccccc2)s1
InChIKey
GUHPRPJDBZHYCJ-UHFFFAOYSA-N
Molecular formula
C14H12O3S
Average molar mass
260.31 g/mol
Monoisotopic mass
260.05071541

Overview

Tiaprofenic acid is an aromatic ketone that is thiophene substituted at C-2 by benzoyl and at C-4 by a 1-carboxyethyl group. It has a role as a non-steroidal anti-inflammatory drug and a drug allergen. It is a monocarboxylic acid, a member of thiophenes and an aromatic ketone.

Names & identifiers

Preferred name
Tiaprofenic Acid
IUPAC
2-(5-benzoylthiophen-2-yl)propanoic acid
English name
Tiaprofenic acid
Molecular formula
C14H12O3S
Molecular weight
260.31

Names & synonyms

tiaprofenic acid33005-95-7Surgam2-(5-benzoylthiophen-2-yl)propanoic acidTiaprofensaeureAcido tiaprofenicotiaprofenAcide tiaprofenique5-Benzoyl-alpha-methyl-2-thiopheneacetic acidAcidum tiaprofenicum2-(5-Benzyl-2-thienyl)propionsaeureFC 3001
Show more names
TiaprofenicSuralganSurgam SATiaprofenicAci
RU 15060TiaprofenateDTXSID5023665alpha-methyl-5-benzoyl-2-thienylacetic acid1LS1T6R34CRU-15060CHEBI:322215-benzoyl-alpha-methylthiophene-2-acetic acid

Database identifiers

CAS
33005-95-7
PubChem CID
5468
DTXSID
DTXSID5023665
ChEMBL
CHEMBL365795
ChEBI
CHEBI:32221
UNII
1LS1T6R34C
EC Number
251-329-3
Nikkaji
J3.176C

Properties

Computed structural propertiesFilling in

XLogP
3.3
Topological polar surface area
82.6 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
4
Rotatable bonds
4
Heavy atoms
18
Formal charge
0
Complexity
323

Experimental & physicochemical properties

DrugsPharmaceuticals
LogP2.86
Solubility3.24e-02 g/L
Human DrugsPharmaceuticals
Melting Point96 °C
Physical DescriptionSolid
Collision Cross Section155.1 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

Physicochemical properties

Melting point
96 ° · 96° (isopropyl ether)
Boiling point
373.57 °C · 373.57°C (rough estimate)
Density
1.2959 · 1.2959 (rough estimate)
refractive index
1.505 · 1.5050 (estimate)
storage temp.
2 · 2-8°C(protect from light)
solubility
Practically insoluble in water, freely soluble in acetone, in ethanol (96 per cent) and in methylene chloride.
pka
4.05 · 4.05±0.10(Predicted)
form
Solid
color
White to Almost white
λmax
314 nm · 314nm(Phosphate buffer sol.)(lit.)
Merck
14 · 14,9422
Major Application
pharmaceutical (small molecule)
InChI
InChI=1S/C14H12O3S/c1-9(14(16)17)11-7-8-12(18-11)13(15)10-5-3-2-4-6-10/h2-9H,1H3,(H,16,17)
InChIKey
GUHPRPJDBZHYCJ-UHFFFAOYSA-N
SMILES
C1(=CC=C(C(C)C(=O)O)S1)C(=O)C1C=CC=CC=1
EWG's Food Scores
1 · 1
FDA UNII
1 LS1T6R34C · 1LS1T6R34C
ATC code
1 AE11 · M01AE11
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Protein binding
97 · 97-98%
Excreted unchanged in urine
50 · 50 (10% as metabolites)
Volume of distribution
5.4 · 5.4-6.7 Litres
Biological half-life
1.5 · 1.5-2 / -
Symbol(GHS)
6 · GHS06,GHS08
Signal word
Danger
Hazard statements
301 · H301-H361
Precautionary statements
201 · P201-P301+P310+P330
RIDADR
2811 · UN 2811 6.1/PG III
WGK Germany
3 · WGK 3
RTECS
7580000 · XM7580000
HS Code
2934.99 · 2934.99.3000
HazardClass
6.1 · 6.1
PackingGroup
III
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralRepr · Acute Tox. 3 OralRepr. 2

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (88.9%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 9 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (88.9%)

Toxicology

Drug Induced Liver Injury · 4 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Tiaprofenic acid

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Safety data

wgk
WGK 3
rtecs
XM7580000
ridadr
UN 2811 6.1/PG III
hs_code
2934.99.3000
Signal word
Danger
Symbol(GHS)
GHS06,GHS08
hazard_class
6.1
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
III
Hazard statements
H301-H361
Hazard Classifications
Acute Tox. 3 OralRepr. 2
Precautionary statements
P201-P301+P310+P330

Chemistry & industry

Pharmacology

ATC Code · 2 items

M - Musculo-skeletal system

QM - Musculo-skeletal system

Pharmacodynamics · 1 item

Tiaprofenic acid is a non-steroidal anti-inflammatory drug of the arylpropionic acid (profen) class, used to treat pain, especially arthritic pain. The typical adult dose is 300mg twice daily. This drug is not recommended for use in the pediatric population.

Mechanism of Action · 1 item

Tiaprofenic acid belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the production of a chemical (prostaglandin) which the body produces in response to injury or certain diseases. This prostaglandin would otherwise go on to cause swelling, pain and inflammation.

Biological Half-Life1.5-2.5 hours
Metabolism/MetabolitesHepatic (10%). Sparingly metabolised in the liver to two inactive metabolites.
MeSH Pharmacological Classification · 1 item

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Absorption, Distribution and ExcretionBioavailability is 90% following oral administration.
Cellular LocationsCytoplasm
Metabolite PathwaysTiaprofenic Acid Action Pathway

Uses & manufacturing

UsesUse (kg; approx.) in Germany (2009): >250
Use ClassificationPharmaceuticals

Applications

UsesAntiinflammatory;Cyclooxygenase inhibitor

Upstream & downstream products

Upstream raw materials

Benzoyl chloride

Additional notes

DefinitionChEBI: An aromatic ketone that is thiophene substituted at C-2 by benzoyl and at C-4 by a 1-carboxyethyl group.

Related reactions

3 records
New reaction record
HRID 1277794 reaction equation
HRID 1277794As product
HRID 1660473 reaction equation
HRID 1660473As product
HRID 1733646 reaction equation
HRID 1733646As product

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes